Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.79M Hold
13,950
0.29% 46
2026
Q1
$1.68M Sell
13,950
-1,750
-11% -$202K 0.32% 50
2025
Q4
$1.67M Hold
15,700
0.3% 46
2025
Q3
$1.32M Hold
15,700
0.23% 52
2025
Q2
$1.24M Hold
15,700
0.23% 48
2025
Q1
$1.41M Sell
15,700
-4,850
-24% -$453K 0.29% 46
2024
Q4
$2.04M Sell
20,550
-1,150
-5% -$119K 0.4% 43
2024
Q3
$2.46M Hold
21,700
0.48% 42
2024
Q2
$2.69M Hold
21,700
0.56% 40
2024
Q1
$2.86M Hold
21,700
0.61% 42
2023
Q4
$2.37M Hold
21,700
0.53% 41
2023
Q3
$2.23M Hold
21,700
0.56% 39
2023
Q2
$2.5M Hold
21,700
0.59% 40
2023
Q1
$2.31M Hold
21,700
0.59% 40
2022
Q4
$2.41M Hold
21,700
0.68% 39
2022
Q3
$1.87M Hold
21,700
0.53% 41
2022
Q2
$1.98M Hold
21,700
0.55% 42
2022
Q1
$1.78M Hold
21,700
0.4% 43
2021
Q4
$1.66M Hold
21,700
0.34% 44
2021
Q3
$1.63M Hold
21,700
0.37% 44
2021
Q2
$1.69M Sell
21,700
-10,345
-32% -$769K 0.38% 44
2021
Q1
$2.36M Hold
32,045
0.56% 43
2020
Q4
$2.5M Sell
32,045
-11,618
-27% -$889K 0.61% 43
2020
Q3
$3.46M Sell
43,663
-39
-0.1% -$3.06K 0.93% 39
2020
Q2
$3.23M Hold
43,702
0.97% 38
2020
Q1
$3.21M Sell
43,702
-20,960
-32% -$1.65M 1.25% 31
2019
Q4
$5.61M Hold
64,662
1.86% 24
2019
Q3
$5.19M Hold
64,662
1.85% 22
2019
Q2
$5.17M Hold
64,662
1.8% 24
2019
Q1
$5.13M Hold
64,662
1.86% 24
2018
Q4
$4.71M Sell
64,662
-14,436
-18% -$1.02M 2.03% 22
2018
Q3
$5.35M Hold
79,098
1.95% 23
2018
Q2
$4.58M Hold
79,098
1.83% 25
2018
Q1
$4.11M Hold
79,098
1.62% 30
2017
Q4
$4.25M Hold
79,098
1.68% 24
2017
Q3
$4.83M Hold
79,098
1.9% 21
2017
Q2
$4.84M Hold
79,098
1.92% 22
2017
Q1
$4.8M Hold
79,098
1.95% 23
2016
Q4
$4.44M Hold
79,098
1.96% 23
2016
Q3
$4.71M Sell
79,098
-5,476
-6% -$320K 2.03% 21
2016
Q2
$4.65M Hold
84,574
2.07% 21
2016
Q1
$4.27M Hold
84,574
1.94% 23
2015
Q4
$4.26M Buy
+84,574
New +$4.26M 1.9% 21

Other funds holding MRK

Chad R. Baker's MRK Position: Q2 2026 in Review

Chad R. Baker held its Merck (MRK) position steady in Q2 2026 at 13,950 shares worth $1.79M. The position accounts for 0.29% of the portfolio, ranked #46.

Chad R. Baker first reported a position in MRK in Q4 2015 and has held it in 43 quarters since. The position peaked at $5.61M in Q4 2019. 718 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Chad R. Baker held 13,950 shares of Merck worth $1.79M as of Q2 2026.
  • Chad R. Baker left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.29% of Chad R. Baker's portfolio in Q2 2026, its #46 holding.
  • Chad R. Baker first reported a position in Merck in Q4 2015 and has held it in 43 quarters since.
  • Chad R. Baker's Merck position peaked at $5.61M in Q4 2019.
  • 718 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Chad R. Baker's 13F filing for Q2 2026, filed 16 Jul 2026.